Apolipoprotein specificity for lipid efflux by the human ABCAI transporter

被引:270
作者
Remaley, AT
Stonik, JA
Demosky, SJ
Neufeld, EB
Bocharov, AV
Vishnyakova, TG
Eggerman, TL
Patterson, AP
Duverger, NJ
Santamarina-Fojo, S
Brewer, HB
机构
[1] NHLBI, NIH, Bethesda, MD 20892 USA
[2] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA
[3] Aventis Pharma, Dept Genom, Every, France
基金
美国国家卫生研究院;
关键词
Tangier disease; HDL; ABCAI; ABC transporters;
D O I
10.1006/bbrc.2000.4219
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ABCAI, a member of the ATP binding cassette family, mediates the efflux of excess cellular lipid to HDL and is defective in Tangier disease. The apolipoprotein acceptor specificity for Lipid efflux by ABCAI was examined in stably transfected Hela cells, expressing a human ABCAI-GFP fusion protein. ApoA-I and all of the other exchangeable apolipoproteins tested (apoA-II, apoA-IV, apoC-I, apoC-II, apoC-III, apoE) showed greater than a threefold increase in cholesterol and phospholipid efflux from ABCAI-GFP transfected cells compared to control cells. Expression of ABCAI in Hela cells also resulted in a marked increase in specific binding of both apoA-I (Kd = 0.60 mug/mL) and apoA-II (Kd = 0.58 mug/mL) to a common binding site. In summary, ABCAI-mediated cellular binding of apolipoproteins and lipid efflux is not specific for only apoA-I but can also occur with other apolipoproteins that contain multiple amphipathic helical domains. (C) 2001 Academic Press.
引用
收藏
页码:818 / 823
页数:6
相关论文
共 30 条
  • [1] Assmann G, 1995, METABOLIC MOL BASES, P2053
  • [2] PRESENCE AND FORMATION OF FREE APOLIPOPROTEIN A-I-LIKE PARTICLES IN HUMAN PLASMA
    ASZTALOS, BF
    ROHEIM, PS
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (09) : 1419 - 1423
  • [3] The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
    Bodzioch, M
    Orsó, E
    Klucken, T
    Langmann, T
    Böttcher, L
    Diederich, W
    Drobnik, W
    Barlage, S
    Büchler, C
    Porsch-Özcürümez, M
    Kaminski, WE
    Hahmann, HW
    Oette, K
    Rothe, G
    Aslanidis, C
    Lackner, KJ
    Schmitz, G
    [J]. NATURE GENETICS, 1999, 22 (04) : 347 - 351
  • [4] BREWER HB, 1986, METHOD ENZYMOL, V128, P223
  • [5] Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
    Brooks-Wilson, A
    Marcil, M
    Clee, SM
    Zhang, LH
    Roomp, K
    van Dam, M
    Yu, L
    Brewer, C
    Collins, JA
    Molhuizen, HOF
    Loubser, O
    Ouelette, BFF
    Fichter, K
    Ashbourne-Excoffon, KJD
    Sensen, CW
    Scherer, S
    Mott, S
    Denis, M
    Martindale, D
    Frohlich, J
    Morgan, K
    Koop, B
    Pimstone, S
    Kastelein, JJP
    Genest, J
    Hayden, MR
    [J]. NATURE GENETICS, 1999, 22 (04) : 336 - 345
  • [6] DEFECTIVE REMOVAL OF CELLULAR CHOLESTEROL AND PHOSPHOLIPIDS BY APOLIPOPROTEIN-A-I IN TANGIER DISEASE
    FRANCIS, GA
    KNOPP, RH
    ORAM, JF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) : 78 - 87
  • [7] ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine.
    Hamon, Y
    Broccardo, C
    Chambenoit, O
    Luciani, MF
    Toti, F
    Chaslin, S
    Freyssinet, JM
    Devaux, PF
    McNeish, J
    Marguet, D
    Chimini, G
    [J]. NATURE CELL BIOLOGY, 2000, 2 (07) : 399 - 406
  • [8] ALPHA-HELICAL REQUIREMENTS FOR FREE APOLIPOPROTEINS TO GENERATE HDL AND TO INDUCE CELLULAR LIPID EFFLUX
    HARA, H
    HARA, H
    KOMABA, A
    YOKOYAMA, S
    [J]. LIPIDS, 1992, 27 (04) : 302 - 304
  • [9] HOEG JM, 1994, GENETIC FACTORS CORO, P351
  • [10] JACKSON RL, 1986, METHOD ENZYMOL, V128, P223